MedPath

Comparison of ratio of blood components in pyorrhea patients before and after treatment.

Phase 2
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2024/03/064169
Lead Sponsor
DR SURABHI TANDE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Minimum of 20 teeth to be present in every patient and minimum 4 teeth present in each quadrant

Cases of stage three periodontitis CAL greater than or equal to 5mm and PPD greater than or equal to 6mm

Exclusion Criteria

Patients suffering from known systemic diseases and known allergy

Pregnant, lactating and menopause female patients

Patients with habit of any form of tobacco

Patients who have received any antibiotic and or anti-inflammatory drug therapy during past 3 months

Patients who received surgical or nonsurgical periodontal therapy in last 6 months

Patients with autoimmune diseases

Patients with any systemic/ hematologic disorder

Patients with history of fever in last 1 month

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Neutrophil to Lymphocyte ratio and Platelet to Lymphocyte ratio after surgical periodontal therapy in chronic periodontitis patientsTimepoint: 10 weeks
Secondary Outcome Measures
NameTimeMethod
Change in Plaque index (PI) (Silness & Loe, 1964) <br/ ><br>Gingival Index (GI) (Loe & Silness, 1963) <br/ ><br>Modified Sulcus Bleeding Index (Mombelli et al, 1987) <br/ ><br>PROBING POCKET DEPTH(PPD) <br/ ><br>CLINICAL ATTACHMENT LEVEL(CAL) <br/ ><br> <br/ ><br>Timepoint: 10 weeks
© Copyright 2025. All Rights Reserved by MedPath